Strides Nordic ApS: Financial statements 2023
CVR: 40533605
Source: annual report 2023, Danish Business Authority
01/04/2022 – 31/03/2023
Strides Nordic ApS (CVR 40533605) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 9,524,008 and a net result of DKK 6,043,316 compared with DKK -1,776,114 the year before. Equity in the 2023 report amounted to DKK 5,025,690. The solvency ratio was 12.9%.
- Gross Profit
- DKK 9,524,008
- Profit/Loss
- DKK 6,043,316
- Equity
- DKK 5,025,690
- Total Assets
- DKK 38,840,554
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 9.5 mio. | 6 mio. | 5 mio. | 0 |
| 2022 | - | -1.8 mio. | -1.8 mio. | -1 mio. | 0 |
| 2021 | - | 782 t. | 596 t. | 758 t. | - |
| 2020 | - | 161 t. | 122 t. | 162 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Strides Nordic ApS
Strides Nordic ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2019. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Christian Köse Fischer and Amol Jyotirvadan Mehta. The company is owned by Strides Pharma Global PTE. Limited. The company has 5 employees (2026). In 2026, the company reported a gross profit of DKK 416,045 and a net result of DKK -5,658,491 compared with DKK -3,129,210 the year before. Equity in the 2026 report amounted to DKK -3,430,916.